Browse by Poster Presenter

Skip to main content

ICPE 2023 Main banner

ICPE 2023 Program

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Y
Yalamanchili, Priyanka

Daiichi Sankyo, Inc.
(009) Pharmacovigilance of pharmaceutical products in colorectal cancer: a systematic review and metanalysis
Priyanka Yalamanchili
Favorite
Yamoah, Peter

Department of Pharmacy Practice, University of Health and Allied Sciences
(057) Assessment of COVID-19 vaccine-related adverse events in VigiAccess
Peter Yamoah
Favorite
Yang, Avery Shuei He

School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
(027) Increased risk of retinal vascular occlusion in patients receiving cataract surgery: causation or biased association?
Avery Shuei He Yang
Favorite
Yang, Junting

Peking university
(203) Incidence of intussusception among children under 6 years of age in Ningbo, China, 2015-2021: a retrospective cohort study using electronic health records
Junting Yang
Favorite
Yang, Lanting

Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy
(A41) Cardiovascular Risk and Safety of SGLT2 Inhibitors vs DPP-4 Inhibitors: A Nationwide Comparative Effectiveness Research Study
Lanting Yang
Favorite
Yang, Yi-Hsin

National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan
(226) Risk of Type 2 Diabetes Mellitus and Hyperlipidemia in Patients With Chronic Myeloid Leukemia Initiating Tyrosine Kinase Inhibitors: A Nationwide Cohort Study
Yi-Hsin Yang
Favorite
Yang, Yingzi

Department of Epidemiology and Biostatistics, School of Public Health, Peking University
(172) Lifestyle factors and risk of prostate cancer in men with benign prostatic hyperplasia: A cohort study from UK Biobank
Yingzi Yang
Favorite
Yang, Yu

Peking University
(A52) Post-marketing surveillance of human papillomavirus (HPV)-related high-grade cervical disease in a cohort of Chinese women who received the 9-valent HPV vaccine
Yu Yang
Favorite
Yang, Ziming

School of Public Health, Peking University
(225) Bibliometric Analysis Based on Abstracts of the 38th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Ziming Yang
Favorite
Yan, Vincent Ka Chun

The University of Hong Kong
(232) Disease relapse, adverse events and all-cause mortality associated with the use of long-acting injectable antipsychotics versus oral antipsychotics in older people with schizophrenia: a self-controlled case series study
Vincent Ka Chun Yan
Favorite
(236) Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Patients Hospitalized with COVID-19: A Target Trial Emulation Study
Vincent Ka Chun Yan
Favorite
Yefimenko, Natasha

Teamit Institute
(048) Quality compliance while conducting NIS studies: critical success factors assessment and the use of key performance indicators
Natasha Yefimenko
Favorite
(058) The challenges and lessons learnt from conducting COVID-19 monitoring studies through VAC4EU: coordination and management perspective
Natasha Yefimenko
Favorite
Yen, Po-Cheng

Department of Pharmacy, LinKou Chang Gung Memorial Hospital, Taoyuan, Taiwan
(176) Compare the generalizability of dapagliflozin and empagliflozin heart failure phase 3 trials to real-world patients in Taiwan
Po-Cheng Yen
Favorite
Ye, Yizhou

AbbVie Inc.
(145) Identification of Gastrointestinal Perforations in Patients with Inflammatory Bowel Diseases: Challenges and Opportunities in Administrative Claims Data
Yizhou Ye
Favorite
(263) EpidemiologiCal POpulatioN STudy of SARS-CoV-2 in Lake CounTy, Illinois: CONTACT: Recruiting and Engaging Participants
Yizhou Ye
Favorite
Ye, Yun

The Ohio State University
(141) Using administrative data to understand substance misuse patterns in understudied populations: A child welfare sample
Yun Ye
Favorite
Yimgang, Doris

AbbVie Inc.
(083) Treatment Patterns Before, During, and After Pregnancy in Inflammatory Bowel Disease
Doris Yimgang
Favorite
(125) Pregnancy Rates in Patients with Immune-mediated Inflammatory Diseases
Doris Yimgang
Favorite
Yochum, Laura

Optum Epidemiology
(126) Pregnancy during a pandemic: pregnancy occurrence and outcomes during the SARS-CoV-2 pandemic
Laura Yochum
Favorite
Yoon, Dongwon

School of Pharmacy, Sungkyunkwan University, South Korea
(303) Cardiovascular, neurological, and immunological adverse events associated with 23-valent pneumococcal polysaccharide vaccine among older adults: a nationwide self-controlled risk interval study
Dongwon Yoon
Favorite
Yoon, Jinkyoung

College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea
(016) Cardiovascular Adverse Events associated with JAK Inhibitor versus TNF Inhibitor: A Disproportionality Analysis in National Pharmacovigilance Database of Korea
Jinkyoung Yoon
Favorite
Young, Jessica

Karolinska Institutet
(054) Closing the Gap on Inflammatory Bowel Disease Treatments and the Risk of Cancer: an International Collaboration Combining National Registries with Medical Chart Abstraction
Jessica Young
Favorite
Younus, Muhammad

Pfizer Inc USA
(285) Real-world Data Evaluating Safety, Effectiveness and Dosing of Dalteparin for the Treatment of Venous Thromboembolism (VTE) in Neonates Aged 0 to 28 days
Muhammad Younus
Favorite
Yuan, Zhong

Janssen R&D
(164) The Risk of Cardiovascular Events in Patients with Resistant Hypertension
Zhong Yuan
Favorite
Yue, Qun-Ying

Uppsala Monitoring Centre
(055) Time-to-onset of glomerular diseases following COVID-19 vaccination: a case series analysis
Qun-Ying Yue
Favorite